Law360, Washington (December 7, 2015, 6:38 PM EST) -- Genetic Technologies Ltd. urged a Federal Circuit panel Monday to revive a DNA technology patent successfully challenged by Bristol-Myers Squibb Co. for claiming a process found in nature, arguing the patent includes an “inventive concept” for finding genetic variations in DNA.
The company told a three-judge panel that the first claim of its patent applied existing technology “in a brand new way” and should thus be considered eligible.
Inventor Malcolm Simons had allegedly discovered that sequences in noncoding regions of DNA — those that do not contain blueprints for synthesizing proteins — are sometimes inherited together with sequences in coding regions. As a...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!